|
2018 Conference Publication Oncolytic immunotherapy with PV-10Agarwala, Sanjiv, Smithers, B. Mark, Haushild, Axel, Ascierto, Paolo A. and Watcher, Eric (2018). Oncolytic immunotherapy with PV-10. Immunotherapy Bridge 2017, Naples, Italy, 29 November - 2 December 2017. London, United Kingdom: BioMed Central. doi: 10.1186/s12967-017-1352-z |
|
2018 Conference Publication Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanomaChong, S., Green, A., Rowe, C., Malt, M., Brown, S., Smithers, M. and Khosrotehrani, K. (2018). Effect of a previous diagnosis of primary invasive melanoma on the progression of subsequent primary invasive melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Richmond, VIC, Australia: Wiley-Blackwell Publishing. doi: 10.1111/ajd.17_12815 |
|
2017 Conference Publication Outcomes of complex cancer surgery in QueenslandSmithers, Mark, Theile, David E., Philpot, Shoni, Guan, Tracey and Dunn, Nathan (2017). Outcomes of complex cancer surgery in Queensland. COSA's 44th Annual Scientific Meeting, Sydney, NSW Australia, 13-15 November 2017. Chichester, West Sussex United Kingdom: Wiley-Blackwell. doi: 10.1111/ajco.12798 |
|
2017 Conference Publication Long-term health-related quality of life following esophagectomy: A nonrandomized comparison of thoracoscopically assisted and open surgeryBarbour, Andrew P., McCormack, Orla M. , Baker, Peter J., Hirst, Jodi, Krause, Lutz, Brosda, Sandra, Thomas, Janine M., Blazeby, Jane M., Thomson, Iain G., Gotley, David C. and Smithers, Bernard M. (2017). Long-term health-related quality of life following esophagectomy: A nonrandomized comparison of thoracoscopically assisted and open surgery. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/SLA.0000000000001899 |
|
2017 Conference Publication Outcome predictors in median arcuate ligament syndromeHo, Kelvin Kam Fai, Walker, Philip, Smithers, B. Mark, Foster, Wallace, Nathanson, Leslie, O'Rourke, Nicholas, Shaw, Ian and McGahan, Timothy (2017). Outcome predictors in median arcuate ligament syndrome. Royal Australasian College of Surgeons Annual Scientific Congress and the Australia and New Zealand Society for Vascular Surgery Annual Scientific Meeting, Canberra, Australia, 11-13 October 2014. Philadelphia, PA United States: Mosby. doi: 10.1016/j.jvs.2016.11.040 |
|
2016 Conference Publication Intralesional rose bengal for treatment of melanomaAgarwala, Sanjiv S., Andtbacka, Robert Hans Ingemar, Rice, Kristen N., Ross, Merrick I., Scoggins, Charles Raben, Smithers, Bernard Mark, Whitman, Eric D. and Wachter, Eric Andrew (2016). Intralesional rose bengal for treatment of melanoma. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 03-07, 2016. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2016.34.15_suppl.TPS9600 |
|
2016 Conference Publication Intralesional rose bengal for stage III and IV melanomaAgarwala, S. S., Andtbacka, R. H. I., Hauschild, A., Rice, K. N., Ross, M., Scoggins, C. R., Smithers, M., Whitman, E. and Wachter, E. A. (2016). Intralesional rose bengal for stage III and IV melanoma. 41st Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark, 7-11 October, 2016. OXFORD: Oxford University Press. doi: 10.1093/annonc/mdw379.52 |
|
2016 Conference Publication Long-term prospective assessment of quality of life and lymphedema after inguinal or inguinal and pelvic lymphadenectomy for recurrent melanoma in the groinHenderson, M. A., Fisher, R., Di Iulio, J., Gyorki, D., Spillane, J., Speakman, D., Burmeister, B., Smithers, B., Hong, A., Shannon, K., Ainslie, J., Scolyer, R., Carruthers, S., Coventry, B., Babington, S., Duprat, J., Hoekstra, H. and Thompson, J. (2016). Long-term prospective assessment of quality of life and lymphedema after inguinal or inguinal and pelvic lymphadenectomy for recurrent melanoma in the groin. 69th Annual Cancer Symposium of the Society of Surgical Oncology, Boston, United States, Mar 02-05, 2016. New York, United States: Springer New York LLC. doi: 10.1245/s10434-015-5010-5 |
|
2016 Conference Publication A phase 2 study of intralesional PV-10 followed by radiotherapy for localized in transit or recurrent metastatic melanoma.Foote, Matthew C., Burmeister, Bryan H., Thomas, Janine, Read, Tavis and Smithers, Bernard Mark (2016). A phase 2 study of intralesional PV-10 followed by radiotherapy for localized in transit or recurrent metastatic melanoma.. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 02-06, 2017. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/JCO.2016.34.15_suppl.e21072 |
|
2016 Conference Publication Prognostic value of nomograms incorporating biomarkers vs. sentinel node status in patients with stage IB and II melanomaRowe, C., Tang, F., Hughes, M. C., Rodero, M., Malt, M., Lambie, D., Barbour, A., Hayward, N., Smithers, B. M., Green, A. and Khosrotehrani, K. (2016). Prognostic value of nomograms incorporating biomarkers vs. sentinel node status in patients with stage IB and II melanoma. Australasian College of Dermatologists 49th Annual Scientific Meeting, Perth, Australia, 14–17 May, 2016. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12480 |
|
2016 Conference Publication An AGITG trial - A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel plus /-radio Therapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinomaBarbour, A., Walpole, E., Mai, G. T., Chan, H., Barnes, E., Watson, D., Ackland, S., Wills, V., Martin, J., Burge, M., Karapetis, C., Shannon, J., Nott, L., Gebski, V., Wilson, K., Thomas, J., Lampe, G., Zalcberg, J., Simes, J. and Smithers, M. (2016). An AGITG trial - A randomised phase II study of pre-operative cisplatin, fluorouracil and DOCetaxel plus /-radio Therapy based on poOR early response to cisplatin and fluorouracil for resectable esophageal adenocarcinoma. 41st Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Denmark, 7-11 October 2016. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdw371.02 |
|
2015 Conference Publication TOPGEAR: A randomized phase II/III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer. Interim results from an international, intergroup trial of the AGITG/TROG/NCIC CTG/EORTCLeong, T., Smithers, B. M., Michael, M., Gebski, V., Simes, J., Boussioutas, A., Miller, D., Zalcberg, J., O'Connell, R., Swallow, C., Darling, G., Wong, R., Schuhmacher, C., Lordick, F. and Haustermans, K. (2015). TOPGEAR: A randomized phase II/III trial of perioperative ECF chemotherapy versus preoperative chemoradiation plus perioperative ECF chemotherapy for resectable gastric cancer. Interim results from an international, intergroup trial of the AGITG/TROG/NCIC CTG/EORTC. European Cancer Congress, Vienna Austria, 2015. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(15)30043-5 |
|
2015 Conference Publication Glutathione S-transferase P1 Ile105Val polymorphism: phenotypic characteristics and melanoma riskDaley, G. M., Lee, K. J., Jagirdar, K., Smithers, B. M., Duffy, D. L., Sturm, R. A. and Soyer, H. P. (2015). Glutathione S-transferase P1 Ile105Val polymorphism: phenotypic characteristics and melanoma risk. 48th Annual Scientific Meeting of the Australasian College of Dermatologists, Adelaide SA, Australia, 16 May 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337 |
|
2015 Conference Publication Immune cell infiltrate subtypes inform on melanoma survival in stage Ib and II melanomasRowe, C., Tang, F., Rodero, M., Malt, M., Lambie, D., Smithers, M., Green, A. and Khosrotehrani, K. (2015). Immune cell infiltrate subtypes inform on melanoma survival in stage Ib and II melanomas. Australasian College of Dermatologists 48th Annual Scientific Meeting, Adelaide, Australia, 16 May 2015. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337 |
|
2015 Conference Publication Treatment of oesophageal adenocarcinoma-what is the ideal? Results from a survey of Augis and Anzgosa membersCouper, G., Paterson-Brown, S. and Smithers, M. (2015). Treatment of oesophageal adenocarcinoma-what is the ideal? Results from a survey of Augis and Anzgosa members. 2nd Digestive Disorders Federation Conference, London, England, United Kingdom, Jun 22-25, 2015. London, United Kingdom: B M J Group. doi: 10.1136/gutjnl-2015-309861.598 |
|
2015 Conference Publication Complex cancer surgery for rare cancers: Volume-associated outcomes for patients undergoing pancreaticoduodenectomy in QueenslandEden, Tania, Cossio, Danica, Dunn, Nathan, Colquist, Shoni, Guan, Tracey, Tran, Nancy and Smithers, Mark (2015). Complex cancer surgery for rare cancers: Volume-associated outcomes for patients undergoing pancreaticoduodenectomy in Queensland. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12432 |
|
2015 Conference Publication Changing Patterns of Pancreaticoduodenectomy Surgery in QueenslandEden, Tania, Cossio, Danica, Dunn, Nathan, Colquist, Shoni, Guan, Tracey, Tran, Nancy and Smithers, Mark (2015). Changing Patterns of Pancreaticoduodenectomy Surgery in Queensland. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, Australia, 17–19 November, 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/ajco.12432 |
|
2014 Conference Publication Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.Agarwala, Sanjiv S., Thompson, John F., Smithers, B. Mark, Ross, Merrick I., Scoggins, Charles Raben, Coventry, Brendon J., Neuhaus, Susan J., Minor, David R., Singer, Jamie M. and Wachter, Eric Andrew (2014). Efficacy of intralesional Rose Bengal in patients receiving injection of all existing melanoma in phase II study PV-10-MM-02.. 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Chicago Il, May 30-Jun 03, 2014. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. |
|
2014 Conference Publication Subgroup Efficacy in Patients Receiving Intralesional Rose Bengal to All Existing Melanoma in Phase II Study Pv-10-Mm-02Agarwala, S., Thompson, J. F., Smithers, B. M., Ross, M., Scoggins, C. R., Coventry, B. J., Neuhaus, S. J., Minor, D. R., Singer, J. M. and Wachter, E. (2014). Subgroup Efficacy in Patients Receiving Intralesional Rose Bengal to All Existing Melanoma in Phase II Study Pv-10-Mm-02. 39th European Society for Medical Oncology Congress (ESMO), Madrid, Spain, 26-30 September 2014. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/annonc/mdu344.36 |
|
2014 Conference Publication Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.Cebon, Jonathan S., McArthur, Grant A., Chen, Weisan, Davis, Ian D., Gore, Martin Eric, Thompson, John F., Millward, Michael, Findlay, Michael P. N., Dunbar, Rod, Ottensmeier, Christian H. H., Venhaus, Ralph Rudolph, Nathan, Paul D., Dalgleish, Angus George, Cerundolo, Vincenzo, Maraskovsky, Eugene, Hopkins, Wendie, Marsden, Jeremy, Smithers, B. Mark, Hersey, Peter and Evans, T. R. Jeffry (2014). Randomized, double-blind phase II trial of NY-ESO-1 ISCOMATRIX vaccine and ISCOMATRIX adjuvant alone in patients with resected stage IIc, III, or IV malignant melanoma.. 50th Annual Meeting of the American Society of Clinical Oncology, Chicago, Illinois, 30 May - 3 June 2014 . Alexandria, VA, United States: American Society of Clinical Oncology. |
